Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma
NCT00609817
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class
Stopped
Lack of funding
Conditions
Multiple Myeloma
Interventions
DRUG:
GCS-100
DRUG:
Bortezomib/Dexamethasone
Sponsor
La Jolla Pharmaceutical Company